Author/Authors :
alishiri, gholamhossein baqiyatallah university of medical sciences, Tehran, Iran , moshkani farahani, maryam baqiyatallah university of medical sciences - atherosclerosis research center, Tehran, Iran , sadr, ali baqiyatallah university of medical sciences - atherosclerosis research center, Tehran, Iran , salesi, mahmood baqiyatallah university of medical sciences - chemical injuries research center, systems biology and poisonings institute, Tehran, Iran , rahemi, mostafa baqiyatallah university of medical sciences - atherosclerosis research center, Tehran, Iran , rezapoor, bahador baqiyatallah university of medical sciences - atherosclerosis research center, Tehran, Iran
Abstract :
Introduction: Coronary Artery Disease (CAD) is known as the major cause of morbidity and mortality in the world with a growing trend, especially in some developing countries. CAD commonly observed in elderly cases, however; recently it is usually found in young adults. In this study, we aimed to evaluate the prevalence of anti-phospholipid antibody syndrome (APS) in patients with premature CAD. Methods: The cross-sectional study was conducted in Baqiyatallah hospital from April 2012 to April 2016. Patients with premature CAD were included in the study. The data regarding the laboratory tests, echocardiography, and angiography were obtained from all cases. Results: Overall 133 eligible patients were included in the study. In the first set of the laboratory test, 18 patients were recognized to have APS (13.53%). The second confirmatory APA test was showing 3 of 18 patients were considered to have APS (2.25%). Conclusion: The results showed there is an association between the risk of developing Premature CAD and APS could potentially. The APS may have significant effects on the risk of coronary heart disease, especially in young adults.
Keywords :
Anti , phospholipid Syndrome , Premature Coronary Artery , Disease , Risk Factors
